John A Roberts - Net Worth and Insider Trading

John A Roberts Net Worth

The estimated net worth of John A Roberts is at least $47,280 dollars as of 2024-12-27. John A Roberts is the CEO of Cancer Genetics Inc and owns about 9,921 shares of Cancer Genetics Inc (CGIX) stock worth over $45,736. John A Roberts is also the CEO of Vyant Bio Inc and owns about 7,961 shares of Vyant Bio Inc (VYNT) stock worth over $1,544. Details can be seen in John A Roberts's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John A Roberts has not made any transactions after 2021-11-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of John A Roberts

To

John A Roberts Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, John A Roberts owns 2 companies in total, including Cancer Genetics Inc (CGIX) , and Vyant Bio Inc (VYNT) .

Click here to see the complete history of John A Roberts’s form 4 insider trades.

Insider Ownership Summary of John A Roberts

Ticker Comapny Transaction Date Type of Owner
CGIX Cancer Genetics Inc 2019-01-31 Chief Executive Officer
VYNT Vyant Bio Inc 2021-11-24 Chief Executive Officer

John A Roberts Latest Holdings Summary

John A Roberts currently owns a total of 2 stocks. Among these stocks, John A Roberts owns 9,921 shares of Cancer Genetics Inc (CGIX) as of January 31, 2019, with a value of $45,736 and a weighting of 96.73%. John A Roberts also owns 7,961 shares of Vyant Bio Inc (VYNT) as of November 24, 2021, with a value of $1,544 and a weighting of 3.27%.

Latest Holdings of John A Roberts

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CGIX Cancer Genetics Inc 2019-01-31 9,921 4.61 45,736
VYNT Vyant Bio Inc 2021-11-24 7,961 0.19 1,544

Holding Weightings of John A Roberts


John A Roberts Form 4 Trading Tracker

According to the SEC Form 4 filings, John A Roberts has made a total of 0 transactions in Cancer Genetics Inc (CGIX) over the past 5 years. The most-recent trade in Cancer Genetics Inc is the acquisition of 6,181 shares on January 31, 2019, which cost John A Roberts around $42,650.

According to the SEC Form 4 filings, John A Roberts has made a total of 3 transactions in Vyant Bio Inc (VYNT) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Vyant Bio Inc is the acquisition of 1,000 shares on November 24, 2021, which cost John A Roberts around $10,100.

Insider Trading History of John A Roberts

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

John A Roberts Trading Performance

GuruFocus tracks the stock performance after each of John A Roberts's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John A Roberts is -16.08%. GuruFocus also compares John A Roberts's trading performance to market benchmark return within the same time period. The performance of stocks bought by John A Roberts within 3 months outperforms 0 times out of 6 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how John A Roberts's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of John A Roberts

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 6 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -1.88 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -5.22 LIMIT LIMIT LIMIT LIMIT LIMIT

John A Roberts Ownership Network

Ownership Network List of John A Roberts

No Data

Ownership Network Relation of John A Roberts

Insider Network Chart

John A Roberts Owned Company Details

What does Cancer Genetics Inc do?

Who are the key executives at Cancer Genetics Inc?

John A Roberts is the Chief Executive Officer of Cancer Genetics Inc. Other key executives at Cancer Genetics Inc include President & Discovery Services Ralf Brandt , Chief Financial Officer Michael Glenn Miles , and EVP Precision Medicine William Lansing Finger .

Cancer Genetics Inc (CGIX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Cancer Genetics Inc (CGIX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cancer Genetics Inc (CGIX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Cancer Genetics Inc (CGIX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cancer Genetics Inc Insider Transactions

No Available Data

John A Roberts Mailing Address

Above is the net worth, insider trading, and ownership report for John A Roberts. You might contact John A Roberts via mailing address: C/o Cancer Genetics, Inc., 201 Route 17 North, 2nd Floor, Rutherford Nj 07070.

Discussions on John A Roberts

No discussions yet.